Psychedelic depression treatments, such as psilocybin or ketamine, impact the same neurotransmitter systems as traditional medication treatments. Psychedelic depression treatments, such as psilocybin:
a) Are primarily based on cognitive-behavioral principles
b) Target serotonin and glutamate receptors in the brain
c) Focus on altering unconscious conflicts
d) Are not supported by empirical evidence